PDB Short entry for 2A91 HEADER SIGNALING PROTEIN,TRANSFERASE,MEMBRANE P11-JUL-05 2A91 TITLE CRYSTAL STRUCTURE OF ERBB2 DOMAINS 1-3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 1-510 + FLAG PEPTIDE; COMPND 5 SYNONYM: P185ERBB2; C-ERBB-2; NEU PROTO-ONCOGENE; TYROSINE KINASE- COMPND 6 TYPE CELL SURFACE RECEPTOR HER2; MLN 19; COMPND 7 EC: 2.7.1.112; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ERBB2, HER2, NEU, NGL; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: LEC8; SOURCE 10 EXPRESSION_SYSTEM_CELL: HAMPSTER OVARY CELLS; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS TYROSINE KINASE RECEPTOR; CELL-SURFACE RECEPTOR, SIGNALING PROTEIN, KEYWDS 2 TRANSFERASE, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR T.P.J.GARRETT,N.M.MCKERN,M.LOU,T.C.ELLEMAN,T.E.ADAMS,G.O.LOVRECZ, AUTHOR 2 M.KOFLER,R.N.JORISSEN,E.C.NICE,A.W.BURGESS REVDAT 5 21-DEC-22 2A91 1 SEQADV HETSYN REVDAT 4 29-JUL-20 2A91 1 COMPND REMARK SEQADV HETNAM REVDAT 4 2 1 LINK SITE ATOM REVDAT 3 13-JUL-11 2A91 1 VERSN REVDAT 2 24-FEB-09 2A91 1 VERSN REVDAT 1 26-JUL-05 2A91 0 JRNL AUTH T.P.J.GARRETT,N.M.MCKERN,M.LOU,T.C.ELLEMAN,T.E.ADAMS, JRNL AUTH 2 G.O.LOVRECZ,M.KOFLER,R.N.JORISSEN,E.C.NICE,A.W.BURGESS JRNL TITL THE CRYSTAL STRUCTURE OF A TRUNCATED ERBB2 ECTODOMAIN JRNL TITL 2 REVEALS AN ACTIVE CONFORMATION, POISED TO INTERACT WITH JRNL TITL 3 OTHER ERBB RECEPTORS JRNL REF MOL.CELL V. 11 495 2003 JRNL REFN ISSN 1097-2765 JRNL PMID 12620236 JRNL DOI 10.1016/S1097-2765(03)00048-0 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 23959 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1203 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3852 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 134 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -14.23700 REMARK 3 B22 (A**2) : 2.16200 REMARK 3 B33 (A**2) : 12.07500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.414 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : OVERALL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.479 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.588 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.008 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.136 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2A91 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JUL-05. REMARK 100 THE DEPOSITION ID IS D_1000033638. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JAN-01 REMARK 200 TEMPERATURE (KELVIN) : 103 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : AXCO CAPILLARY REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22321 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.7 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 75.4 REMARK 200 DATA REDUNDANCY IN SHELL : 7.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.74100 REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 1500, GLYCEROL, PH 5.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.97850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.03150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.12150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.03150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.97850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.12150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 103 REMARK 465 ASN A 104 REMARK 465 THR A 105 REMARK 465 THR A 106 REMARK 465 TYR A 511 REMARK 465 LYS A 512 REMARK 465 ASP A 513 REMARK 465 ASP A 514 REMARK 465 ASP A 515 REMARK 465 ASP A 516 REMARK 465 LYS A 517 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 102 CG CD1 CD2 REMARK 470 PRO A 107 CG CD REMARK 470 VAL A 108 CG1 CG2 REMARK 470 THR A 109 OG1 CG2 REMARK 470 LYS A 179 CD CE NZ REMARK 470 LEU A 210 CG CD1 CD2 REMARK 470 HIS A 297 CG ND1 CD2 CE1 NE2 REMARK 470 ASN A 298 OD1 ND2 REMARK 470 LYS A 312 CG CD CE NZ REMARK 470 SER A 314 OG REMARK 470 LEU A 493 CG CD1 CD2 REMARK 470 ASN A 509 OD1 ND2 REMARK 470 ASP A 510 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 138 C - N - CA ANGL. DEV. = 10.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 8 -169.77 -119.28 REMARK 500 ASP A 9 55.83 -156.19 REMARK 500 LYS A 11 -127.43 53.47 REMARK 500 PRO A 74 76.94 -61.23 REMARK 500 ASN A 90 -31.43 -133.88 REMARK 500 ASP A 97 55.42 29.97 REMARK 500 PRO A 101 -147.71 -81.91 REMARK 500 VAL A 108 -72.76 -69.40 REMARK 500 TYR A 142 -18.14 70.83 REMARK 500 ALA A 159 60.15 -68.47 REMARK 500 ASN A 166 105.49 -51.39 REMARK 500 LYS A 179 -88.91 -40.00 REMARK 500 ARG A 196 -70.23 -127.46 REMARK 500 ALA A 221 -34.45 72.81 REMARK 500 HIS A 236 -73.29 -129.14 REMARK 500 HIS A 239 76.28 -106.89 REMARK 500 ASN A 281 -2.67 79.76 REMARK 500 VAL A 287 23.49 -78.35 REMARK 500 LEU A 296 -89.18 -13.40 REMARK 500 THR A 307 100.35 -58.06 REMARK 500 LYS A 315 -74.68 -86.70 REMARK 500 GLU A 327 -119.77 38.68 REMARK 500 ASN A 339 -11.80 -144.10 REMARK 500 GLN A 377 1.85 -66.61 REMARK 500 ALA A 419 -39.88 -133.36 REMARK 500 CYS A 454 -166.08 -117.86 REMARK 500 ALA A 495 -71.36 -30.92 REMARK 500 PRO A 502 -70.14 -63.34 REMARK 500 ASN A 509 70.40 34.51 REMARK 500 REMARK 500 REMARK: NULL DBREF 2A91 A 1 509 UNP P04626 ERBB2_HUMAN 22 530 SEQADV 2A91 LYS A 309 UNP P04626 ARG 330 CONFLICT SEQADV 2A91 LYS A 496 UNP P04626 ARG 517 CONFLICT SEQADV 2A91 ASP A 510 UNP P04626 EXPRESSION TAG SEQADV 2A91 TYR A 511 UNP P04626 EXPRESSION TAG SEQADV 2A91 LYS A 512 UNP P04626 EXPRESSION TAG SEQADV 2A91 ASP A 513 UNP P04626 EXPRESSION TAG SEQADV 2A91 ASP A 514 UNP P04626 EXPRESSION TAG SEQADV 2A91 ASP A 515 UNP P04626 EXPRESSION TAG SEQADV 2A91 ASP A 516 UNP P04626 EXPRESSION TAG SEQADV 2A91 LYS A 517 UNP P04626 EXPRESSION TAG SEQRES 1 A 517 SER THR GLN VAL CYS THR GLY THR ASP MET LYS LEU ARG SEQRES 2 A 517 LEU PRO ALA SER PRO GLU THR HIS LEU ASP MET LEU ARG SEQRES 3 A 517 HIS LEU TYR GLN GLY CYS GLN VAL VAL GLN GLY ASN LEU SEQRES 4 A 517 GLU LEU THR TYR LEU PRO THR ASN ALA SER LEU SER PHE SEQRES 5 A 517 LEU GLN ASP ILE GLN GLU VAL GLN GLY TYR VAL LEU ILE SEQRES 6 A 517 ALA HIS ASN GLN VAL ARG GLN VAL PRO LEU GLN ARG LEU SEQRES 7 A 517 ARG ILE VAL ARG GLY THR GLN LEU PHE GLU ASP ASN TYR SEQRES 8 A 517 ALA LEU ALA VAL LEU ASP ASN GLY ASP PRO LEU ASN ASN SEQRES 9 A 517 THR THR PRO VAL THR GLY ALA SER PRO GLY GLY LEU ARG SEQRES 10 A 517 GLU LEU GLN LEU ARG SER LEU THR GLU ILE LEU LYS GLY SEQRES 11 A 517 GLY VAL LEU ILE GLN ARG ASN PRO GLN LEU CYS TYR GLN SEQRES 12 A 517 ASP THR ILE LEU TRP LYS ASP ILE PHE HIS LYS ASN ASN SEQRES 13 A 517 GLN LEU ALA LEU THR LEU ILE ASP THR ASN ARG SER ARG SEQRES 14 A 517 ALA CYS HIS PRO CYS SER PRO MET CYS LYS GLY SER ARG SEQRES 15 A 517 CYS TRP GLY GLU SER SER GLU ASP CYS GLN SER LEU THR SEQRES 16 A 517 ARG THR VAL CYS ALA GLY GLY CYS ALA ARG CYS LYS GLY SEQRES 17 A 517 PRO LEU PRO THR ASP CYS CYS HIS GLU GLN CYS ALA ALA SEQRES 18 A 517 GLY CYS THR GLY PRO LYS HIS SER ASP CYS LEU ALA CYS SEQRES 19 A 517 LEU HIS PHE ASN HIS SER GLY ILE CYS GLU LEU HIS CYS SEQRES 20 A 517 PRO ALA LEU VAL THR TYR ASN THR ASP THR PHE GLU SER SEQRES 21 A 517 MET PRO ASN PRO GLU GLY ARG TYR THR PHE GLY ALA SER SEQRES 22 A 517 CYS VAL THR ALA CYS PRO TYR ASN TYR LEU SER THR ASP SEQRES 23 A 517 VAL GLY SER CYS THR LEU VAL CYS PRO LEU HIS ASN GLN SEQRES 24 A 517 GLU VAL THR ALA GLU ASP GLY THR GLN LYS CYS GLU LYS SEQRES 25 A 517 CYS SER LYS PRO CYS ALA ARG VAL CYS TYR GLY LEU GLY SEQRES 26 A 517 MET GLU HIS LEU ARG GLU VAL ARG ALA VAL THR SER ALA SEQRES 27 A 517 ASN ILE GLN GLU PHE ALA GLY CYS LYS LYS ILE PHE GLY SEQRES 28 A 517 SER LEU ALA PHE LEU PRO GLU SER PHE ASP GLY ASP PRO SEQRES 29 A 517 ALA SER ASN THR ALA PRO LEU GLN PRO GLU GLN LEU GLN SEQRES 30 A 517 VAL PHE GLU THR LEU GLU GLU ILE THR GLY TYR LEU TYR SEQRES 31 A 517 ILE SER ALA TRP PRO ASP SER LEU PRO ASP LEU SER VAL SEQRES 32 A 517 PHE GLN ASN LEU GLN VAL ILE ARG GLY ARG ILE LEU HIS SEQRES 33 A 517 ASN GLY ALA TYR SER LEU THR LEU GLN GLY LEU GLY ILE SEQRES 34 A 517 SER TRP LEU GLY LEU ARG SER LEU ARG GLU LEU GLY SER SEQRES 35 A 517 GLY LEU ALA LEU ILE HIS HIS ASN THR HIS LEU CYS PHE SEQRES 36 A 517 VAL HIS THR VAL PRO TRP ASP GLN LEU PHE ARG ASN PRO SEQRES 37 A 517 HIS GLN ALA LEU LEU HIS THR ALA ASN ARG PRO GLU ASP SEQRES 38 A 517 GLU CYS VAL GLY GLU GLY LEU ALA CYS HIS GLN LEU CYS SEQRES 39 A 517 ALA LYS GLY HIS CYS TRP GLY PRO GLY PRO THR GLN CYS SEQRES 40 A 517 VAL ASN ASP TYR LYS ASP ASP ASP ASP LYS MODRES 2A91 ASN A 47 ASN GLYCOSYLATION SITE MODRES 2A91 ASN A 166 ASN GLYCOSYLATION SITE MODRES 2A91 ASN A 238 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET NAG A 911 14 HET NAG A 941 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG 4(C8 H15 N O6) FORMUL 5 HOH *134(H2 O) HELIX 1 1 SER A 17 GLN A 30 1 14 HELIX 2 2 LEU A 50 GLN A 54 5 5 HELIX 3 3 LEU A 86 ASP A 89 5 4 HELIX 4 4 LEU A 147 PHE A 152 1 6 HELIX 5 5 LEU A 210 CYS A 214 5 5 HELIX 6 6 MET A 326 VAL A 332 5 7 HELIX 7 7 ASN A 339 ALA A 344 5 6 HELIX 8 8 LEU A 356 GLY A 362 1 7 HELIX 9 9 ASP A 363 ASN A 367 5 5 HELIX 10 10 GLU A 374 LEU A 382 5 9 HELIX 11 11 LEU A 401 GLN A 405 5 5 HELIX 12 12 LEU A 415 GLY A 418 5 4 HELIX 13 13 PRO A 460 PHE A 465 1 6 HELIX 14 14 PRO A 479 GLU A 486 1 8 HELIX 15 15 GLY A 503 CYS A 507 5 5 SHEET 1 A 5 VAL A 4 THR A 6 0 SHEET 2 A 5 VAL A 34 GLN A 36 1 O GLN A 36 N CYS A 5 SHEET 3 A 5 GLU A 58 VAL A 59 1 O GLU A 58 N VAL A 35 SHEET 4 A 5 ILE A 80 VAL A 81 1 O ILE A 80 N VAL A 59 SHEET 5 A 5 GLU A 126 ILE A 127 1 O GLU A 126 N VAL A 81 SHEET 1 B 5 LEU A 39 THR A 42 0 SHEET 2 B 5 VAL A 63 ALA A 66 1 O LEU A 64 N LEU A 41 SHEET 3 B 5 TYR A 91 LEU A 96 1 O ALA A 94 N VAL A 63 SHEET 4 B 5 GLY A 131 GLN A 135 1 O LEU A 133 N LEU A 93 SHEET 5 B 5 THR A 161 ILE A 163 1 O LEU A 162 N ILE A 134 SHEET 1 C 2 CYS A 219 CYS A 223 0 SHEET 2 C 2 CYS A 231 CYS A 234 -1 O LEU A 232 N GLY A 222 SHEET 1 D 2 PHE A 237 HIS A 239 0 SHEET 2 D 2 ILE A 242 GLU A 244 -1 O ILE A 242 N HIS A 239 SHEET 1 E 2 VAL A 251 TYR A 253 0 SHEET 2 E 2 SER A 260 PRO A 262 -1 O MET A 261 N THR A 252 SHEET 1 F 2 TYR A 268 PHE A 270 0 SHEET 2 F 2 SER A 273 VAL A 275 -1 O VAL A 275 N TYR A 268 SHEET 1 G 2 LEU A 283 SER A 284 0 SHEET 2 G 2 CYS A 290 THR A 291 -1 O THR A 291 N LEU A 283 SHEET 1 H 2 GLN A 299 THR A 302 0 SHEET 2 H 2 GLN A 308 GLU A 311 -1 O GLU A 311 N GLN A 299 SHEET 1 I 5 CYS A 321 TYR A 322 0 SHEET 2 I 5 LYS A 348 PHE A 350 1 O PHE A 350 N CYS A 321 SHEET 3 I 5 GLU A 384 ILE A 385 1 O GLU A 384 N ILE A 349 SHEET 4 I 5 VAL A 409 ILE A 410 1 O VAL A 409 N ILE A 385 SHEET 5 I 5 GLU A 439 LEU A 440 1 O GLU A 439 N ILE A 410 SHEET 1 J 5 LEU A 353 PHE A 355 0 SHEET 2 J 5 LEU A 389 ILE A 391 1 O TYR A 390 N PHE A 355 SHEET 3 J 5 TYR A 420 GLN A 425 1 O SER A 421 N LEU A 389 SHEET 4 J 5 LEU A 444 HIS A 448 1 O LEU A 446 N LEU A 422 SHEET 5 J 5 LEU A 472 THR A 475 1 O LEU A 473 N ALA A 445 SSBOND 1 CYS A 5 CYS A 32 1555 1555 2.02 SSBOND 2 CYS A 141 CYS A 171 1555 1555 2.03 SSBOND 3 CYS A 174 CYS A 183 1555 1555 2.04 SSBOND 4 CYS A 178 CYS A 191 1555 1555 2.03 SSBOND 5 CYS A 199 CYS A 206 1555 1555 2.03 SSBOND 6 CYS A 203 CYS A 214 1555 1555 2.03 SSBOND 7 CYS A 215 CYS A 223 1555 1555 2.03 SSBOND 8 CYS A 219 CYS A 231 1555 1555 2.02 SSBOND 9 CYS A 234 CYS A 243 1555 1555 2.04 SSBOND 10 CYS A 247 CYS A 274 1555 1555 2.02 SSBOND 11 CYS A 278 CYS A 290 1555 1555 2.03 SSBOND 12 CYS A 294 CYS A 310 1555 1555 2.03 SSBOND 13 CYS A 313 CYS A 317 1555 1555 2.03 SSBOND 14 CYS A 321 CYS A 346 1555 1555 2.03 SSBOND 15 CYS A 454 CYS A 483 1555 1555 2.04 SSBOND 16 CYS A 490 CYS A 499 1555 1555 2.04 SSBOND 17 CYS A 494 CYS A 507 1555 1555 2.04 LINK ND2 ASN A 47 C1 NAG A 911 1555 1555 1.45 LINK ND2 ASN A 166 C1 NAG A 941 1555 1555 1.45 LINK ND2 ASN A 238 C1 NAG B 1 1555 1555 1.45 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.39 CRYST1 75.957 82.243 110.063 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013165 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012159 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009086 0.00000